Novel Imaging Software Aids Diagnosis of Neurodegenerative Diseases
By MedImaging International staff writers Posted on 11 Feb 2020 |

Image: A software platform aids early detection of neurodegenerative diseases (Photo courtesy of Qynapse)
A new software platform quantifies magnetic resonance imaging (MRI) markers to support early diagnosis and clinical monitoring of central nervous system (CNS) degenerative disorders.
Qynapse (Paris, France) QyScore software is designed to provide automatic segmentation, labeling, visualization, and volumetric quantification of brain structures such as grey matter, white matter, hippocampus, amygdala, and white matter hyperintensities from a set of MRI scans. Outputs include an electronic report and color overlays of the segmentation on the input images, displayed in a dedicated graphical user interface (GUI) that allows the user to browse segmentations, compare the results to a reference healthy population, and read and edit a PDF report.
QyScore integrates with radiology information system (RIS) and picture archiving and communication system (PACS), and can be operated with MRI scans from 1.5T and 3T scanners for T1 MRI processing, and 3T scanners for T2-weighed fluid attenuated inversion recovery (FLAIR) processing. Quantification and brain segmentation are based on a probabilistic atlas and image intensity information, and volume calculations of the segmented brain structures, with the volumes normalized to allow for the statistical comparison with normative datasets.
“QyScore makes a difference for the diagnosis of dementias at an early stage of the disease when it remains a challenge,” said professor of neurology Bruno Dubois, MD, director of the Memory and Alzheimer's Disease Institute at Pitié Salpêtrière Hospital (Paris, France). “The automatic quantification of markers such as brain atrophy, white matter hyperintensities, and more, provides highly valuable help to support a timely diagnosis and an efficient monitoring of disease progression.”
Quantitative analysis of MRI data has become useful in both research and clinical studies, and crucial for the diagnosis and disease monitoring of patients with Multiple Sclerosis, Alzheimer’s disease, or vascular dementia. These pathologies are characterized by the presence of white matter or lesions, detectable on MRI scans as hyperintense areas on T2-weighed FLAIR images.
Related Links:
Qynapse
Pitié Salpêtrière Hospital
Qynapse (Paris, France) QyScore software is designed to provide automatic segmentation, labeling, visualization, and volumetric quantification of brain structures such as grey matter, white matter, hippocampus, amygdala, and white matter hyperintensities from a set of MRI scans. Outputs include an electronic report and color overlays of the segmentation on the input images, displayed in a dedicated graphical user interface (GUI) that allows the user to browse segmentations, compare the results to a reference healthy population, and read and edit a PDF report.
QyScore integrates with radiology information system (RIS) and picture archiving and communication system (PACS), and can be operated with MRI scans from 1.5T and 3T scanners for T1 MRI processing, and 3T scanners for T2-weighed fluid attenuated inversion recovery (FLAIR) processing. Quantification and brain segmentation are based on a probabilistic atlas and image intensity information, and volume calculations of the segmented brain structures, with the volumes normalized to allow for the statistical comparison with normative datasets.
“QyScore makes a difference for the diagnosis of dementias at an early stage of the disease when it remains a challenge,” said professor of neurology Bruno Dubois, MD, director of the Memory and Alzheimer's Disease Institute at Pitié Salpêtrière Hospital (Paris, France). “The automatic quantification of markers such as brain atrophy, white matter hyperintensities, and more, provides highly valuable help to support a timely diagnosis and an efficient monitoring of disease progression.”
Quantitative analysis of MRI data has become useful in both research and clinical studies, and crucial for the diagnosis and disease monitoring of patients with Multiple Sclerosis, Alzheimer’s disease, or vascular dementia. These pathologies are characterized by the presence of white matter or lesions, detectable on MRI scans as hyperintense areas on T2-weighed FLAIR images.
Related Links:
Qynapse
Pitié Salpêtrière Hospital
Latest General/Advanced Imaging News
- CT Colonography Beats Stool DNA Testing for Colon Cancer Screening
- First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
- AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
- CT-Based Deep Learning-Driven Tool to Enhance Liver Cancer Diagnosis
- AI-Powered Imaging System Improves Lung Cancer Diagnosis
- AI Model Significantly Enhances Low-Dose CT Capabilities
- Ultra-Low Dose CT Aids Pneumonia Diagnosis in Immunocompromised Patients
- AI Reduces CT Lung Cancer Screening Workload by Almost 80%
- Cutting-Edge Technology Combines Light and Sound for Real-Time Stroke Monitoring
- AI System Detects Subtle Changes in Series of Medical Images Over Time
- New CT Scan Technique to Improve Prognosis and Treatments for Head and Neck Cancers
- World’s First Mobile Whole-Body CT Scanner to Provide Diagnostics at POC
- Comprehensive CT Scans Could Identify Atherosclerosis Among Lung Cancer Patients
- AI Improves Detection of Colorectal Cancer on Routine Abdominopelvic CT Scans
- Super-Resolution Technology Enhances Clinical Bone Imaging to Predict Osteoporotic Fracture Risk
- AI-Powered Abdomen Map Enables Early Cancer Detection
Channels
Radiography
view channel
AI Helps Radiologists Spot More Lesions in Mammograms
Breast cancer is a critical health issue, and accurate detection through mammography is essential for effective treatment. However, interpreting mammograms can be challenging for radiologists, particularly... Read more
AI Detects Fatty Liver Disease from Chest X-Rays
Fatty liver disease, which results from excess fat accumulation in the liver, is believed to impact approximately one in four individuals globally. If not addressed in time, it can progress to severe conditions... Read moreMRI
view channel
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read more
New MRI Technique Reveals Hidden Heart Issues
Traditional exercise stress tests conducted within an MRI machine require patients to lie flat, a position that artificially improves heart function by increasing stroke volume due to gravity-driven blood... Read moreUltrasound
view channel
Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery
Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more
New Medical Ultrasound Imaging Technique Enables ICU Bedside Monitoring
Ultrasound computed tomography (USCT) presents a safer alternative to imaging techniques like X-ray computed tomography (commonly known as CT or “CAT” scans) because it does not produce ionizing radiation.... Read moreNuclear Medicine
view channel
Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more
New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
Prostate cancer is the second leading cause of cancer-related death among men in the United States. However, the majority of older men diagnosed with prostate cancer have slow-growing, low-risk forms of... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more